Erratum: Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923
J Surg Oncol
.
2018 Sep;118(4):722.
doi: 10.1002/jso.24798.
Epub 2017 Jul 28.
Authors
Harry D Bear
1
,
Wen Wan
1
,
André Robidoux
2
,
Peter Rubin
3
,
Steven Limentani
4
,
Richard L White Jr
4
,
James Granfortuna
3
,
Judith O Hopkins
5
,
Dwight Oldham
6
,
Angel Rodriguez
7
,
Amy P Sing
8
Affiliations
1
Virginia Commonwealth University and Massey, Cancer Center, Richmond, Virginia.
2
Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada.
3
Cone Health Cancer Center, Greensboro, North Carolina.
4
Carolinas Medical Center, Charlotte, North Carolina.
5
Forsyth Regional Cancer Center, Winston Salem, North Carolina.
6
Lynchburg Hematology Oncology Clinic, Lynchburg, Virginia.
7
Methodist Hospital, Houston, Texas.
8
Genomic Health, Inc., Redwood City, California.
PMID:
30295942
DOI:
10.1002/jso.24798
No abstract available
Publication types
Published Erratum